Bicara Therapeutics BCAX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's share-based compensation arrangement by share-based payment award, options, forfeitures in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's share-based compensation arrangement by share-based payment award, options, forfeitures in period?
- Bicara Therapeutics (BCAX) reported share-based compensation arrangement by share-based payment award, options, forfeitures in period of 0 in Q1 2026.
- What does share-based compensation arrangement by share-based payment award, options, forfeitures in period mean?
- This metric tracks the number of stock options that were forfeited by employees during the reporting period, typically due to termination of employment or failure to meet vesting conditions. Forfeitures reduce the total compensation expense recognized by the company. Monitoring this helps investors understand employee retention trends and the actual cost of equity incentive programs.